Not applicableStudy completedNCT02279537What this trial is testingReal Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMDWho this might be right forWet Macular Degeneration Bayer 593
Post-approval studies (Phase 4)Study completedNCT02305238What this trial is testingJapanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular DegenerationWho this might be right forWet Macular Degeneration Bayer 288
Early research (Phase 1)Ended earlyNCT00102115What this trial is testingStudy of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular DiseaseWho this might be right forMacular DegenerationChoroidal Neovascularization Light Sciences LLC 27
Testing effectiveness (Phase 2)UnknownNCT00996684What this trial is testingStudy of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular DegenerationWho this might be right forMacular Degeneration University of California, Los Angeles 30
Post-approval studies (Phase 4)Study completedNCT04679935What this trial is testingEfficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Ended earlyNCT01025232What this trial is testingIntravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)Who this might be right forAge Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more David M. Brown, M.D. 88
Testing effectiveness (Phase 2)Ended earlyNCT00094120What this trial is testingMSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)Who this might be right forMacular Degeneration Genaera Corporation 60
Testing effectiveness (Phase 2)Study completedNCT03066258What this trial is testingSafety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD TrialWho this might be right forNeovascular Age-related Macular DegenerationWet Age-related Macular Degeneration REGENXBIO Inc. 42
Large-scale testing (Phase 3)Study completedNCT03823300What this trial is testingEvaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)Who this might be right forWet Macular Degeneration Hoffmann-La Roche 658
Very early researchNot Yet RecruitingNCT06888492What this trial is testingTo Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration Hangzhou Jiayin Biotech Ltd 8
Testing effectiveness (Phase 2)Study completedNCT03861234What this trial is testingTest Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)Who this might be right forWet Macular Degeneration Boehringer Ingelheim 43
Large-scale testing (Phase 3)Active Not RecruitingNCT06668064What this trial is testingA 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56Who this might be right forWet Age Related Macular DegenerationwAMD EyePoint Pharmaceuticals, Inc. 400
Early research (Phase 1)Ended earlyNCT01086761What this trial is testingStudy of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular DegenerationWho this might be right forWet Age-Related Macular Degeneration Allergan 32
Post-approval studies (Phase 4)Study completedNCT05269966What this trial is testingStudy to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)Who this might be right forNeovascular Age-related Macular Degeneration (nAMD) Novartis Pharmaceuticals 105
Early research (Phase 1)Active Not RecruitingNCT05903794What this trial is testingEXG102-031 in Patients With wAMD (Everest)Who this might be right forNeovascular (Wet) Age-related Macular Degeneration (nAMD) Exegenesis Bio 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07129239What this trial is testingHigh Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)Who this might be right forWet Age-related Macular Degeneration (wAMD) Clinique de Retine de l'est 180
Not applicableStudy completedNCT01318941What this trial is testingObserve the Effectiveness and Safety of Ranibizumab in Real Life SettingWho this might be right forWet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionWet Age Related Macular DegenerationDiabetic Macular Edema+1 more Novartis Pharmaceuticals 30,490
Testing effectiveness (Phase 2)Looking for participantsNCT07185841What this trial is testingSafety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration (AMD) Fujian Haixi Pharmaceuticals Co., Ltd. 198
Early research (Phase 1)Ended earlyNCT04594681What this trial is testingA Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular DegenerationWho this might be right forHealthy VolunteersWet Age-related Macular Degeneration Kyowa Kirin Co., Ltd. 116
Testing effectiveness (Phase 2)Study completedNCT05275205What this trial is testingSafety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)Who this might be right forNeovascular Age-related Macular Degeneration Unity Biotechnology, Inc. 51